These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 14206915)

  • 1. PHASE II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS: CANCER OF THE BREAST.
    SEARS ME
    Cancer Chemother Rep; 1964 Aug; 40():43. PubMed ID: 14206915
    [No Abstract]   [Full Text] [Related]  

  • 2. ERYTHEMA IN AREAS OF PREVIOUS IRRADIATION IN PATIENTS TREATED WITH HYDROXYUREA (NSC-32065).
    SEARS ME
    Cancer Chemother Rep; 1964 Aug; 40():31-2. PubMed ID: 14206911
    [No Abstract]   [Full Text] [Related]  

  • 3. HYDROXYUREA (NSC-32065): RESULTS OF A PHASE I STUDY.
    GRIFFITH KM
    Cancer Chemother Rep; 1964 Aug; 40():33-6. PubMed ID: 14206912
    [No Abstract]   [Full Text] [Related]  

  • 4. PHASE II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS: CARCINOMA OF THE LUNG.
    BICKERS JN
    Cancer Chemother Rep; 1964 Aug; 40():45-6. PubMed ID: 14206916
    [No Abstract]   [Full Text] [Related]  

  • 5. PHASE II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS: MISCELLANEOUS TUMORS.
    BLOEDOW CE
    Cancer Chemother Rep; 1964 Aug; 40():39-41. PubMed ID: 14206914
    [No Abstract]   [Full Text] [Related]  

  • 6. PHASE II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS: LEUKEMIA.
    SHULLENBERGER CC
    Cancer Chemother Rep; 1964 Aug; 40():49-50. PubMed ID: 14206918
    [No Abstract]   [Full Text] [Related]  

  • 7. PHASE II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS: UROLOGIC AND GYNECOLOGIC NEOPLASMS.
    HOWE CD; SAMUELS ML
    Cancer Chemother Rep; 1964 Aug; 40():47-8. PubMed ID: 14206917
    [No Abstract]   [Full Text] [Related]  

  • 8. PHASE II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS: MULTIPLE MYELOMA AND LYMPHOMA.
    DAVIS P
    Cancer Chemother Rep; 1964 Aug; 40():51-2. PubMed ID: 14206919
    [No Abstract]   [Full Text] [Related]  

  • 9. STUDY OF SERUM B12 AND FOLATE IN PATIENTS TREATED WITH HYDROXYUREA (NSC-32065).
    THURMAN WG; WATKINS WL
    Cancer Chemother Rep; 1964 Aug; 40():23-5. PubMed ID: 14206909
    [No Abstract]   [Full Text] [Related]  

  • 10. MEGALOBLASTIC ERYTHROPOIESIS INDUCED BY HYDROXYUREA (NSC-32065).
    DE BERGSAGEL DE; FRENKEL EP; ALFREY CP; THURMAN WG
    Cancer Chemother Rep; 1964 Aug; 40():15-7. PubMed ID: 14206906
    [No Abstract]   [Full Text] [Related]  

  • 11. PEDIATRIC CLINICAL TRIALS WITH HYDROXYUREA (NSC-32065).
    FERNBACH DJ
    Cancer Chemother Rep; 1964 Aug; 40():37-8. PubMed ID: 14206913
    [No Abstract]   [Full Text] [Related]  

  • 12. HYDROXYUREA ADMINISTERED INTERMITTENTLY.
    LERNER HJ; BECKLOFF GL
    JAMA; 1965 Jun; 192():1168-70. PubMed ID: 14301045
    [No Abstract]   [Full Text] [Related]  

  • 13. [THERAPEUTICS OF ADVANCED CANCER OF THE BREAST].
    MARINGORRIZ FJ; SOLSONA F; CASTILLORAMIREZ A
    Clin Lab (Zaragoza); 1964 Mar; 77():175-88. PubMed ID: 14157950
    [No Abstract]   [Full Text] [Related]  

  • 14. PHASE II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS: CLINICAL EVALUATION.
    KRAKOFF IH; SAVEL H; MURPHY ML
    Cancer Chemother Rep; 1964 Aug; 40():53-5. PubMed ID: 14206920
    [No Abstract]   [Full Text] [Related]  

  • 15. HYDROXYUREA (NSC-32065)--A PHASE I STUDY.
    BOLTON BH; KAUNG DT; LAWTON RL; WOODS LA
    Cancer Chemother Rep; 1964 Jul; 39():47-51. PubMed ID: 14201275
    [No Abstract]   [Full Text] [Related]  

  • 16. STUDIES ON A METABOLIC DEFECT INDUCED BY HYDROXYUREA (NSC-32065).
    FRENKEL EP; SKINNER WN; SMILEY JD
    Cancer Chemother Rep; 1964 Aug; 40():19-22. PubMed ID: 14206907
    [No Abstract]   [Full Text] [Related]  

  • 17. SYSTEMIC EFFECTS OF ANDROGENIC AND ESTROGENIC HORMONES IN ADVANCED BREAST CANCER.
    KENNEDY BJ
    J Am Geriatr Soc; 1965 Mar; 13():230-5. PubMed ID: 14270629
    [No Abstract]   [Full Text] [Related]  

  • 18. ANTILEUKEMIC ACTIVITY OF HYDROXYUREA (NSC-32065) AND OTHER UREA DERIVATIVES.
    GOLDIN A; VENDITTI JM; MEAD JA; GLYNN JP
    Cancer Chemother Rep; 1964 Aug; 40():57-74. PubMed ID: 14206921
    [No Abstract]   [Full Text] [Related]  

  • 19. VINCRISTINE (NSC-67574): DOSAGE AND RESPONSE IN ADVANCED BREAST CANCER.
    GRINBERG R; NEMOTO T; DAO TL
    Cancer Chemother Rep; 1965 Apr; 45():57-61. PubMed ID: 14328050
    [No Abstract]   [Full Text] [Related]  

  • 20. THE FEASIBILITY OF USING RANDOMIZATION SCHEMES EARLY IN THE CLINICAL TRIALS OF NEW CHEMOTHERAPEUTIC AGENTS: HYDROXYUREA (NSC-32065).
    CARBONE PP; KRANT MJ; MILLER SP; HALL TC; SHNIDER BI; COLSKY J; HORTON J; HOSLEY H; MILLER JM; FREI E
    Clin Pharmacol Ther; 1965; 6():17-24. PubMed ID: 14253279
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.